VIEMED HEALTHCARE, INC. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Unregistered Sales of Equity Securities Not applicable. Company Repurchases of Equity Securities The following table sets forth certain information with respect to repurchases of our common shares during the three months ended March 31, 2022: Period Total number of shares (or units) purchased (1) Average price paid per share Total number of shares purchased as part of publicly announced plans or programs (2) Maximum number of shares that may yet be purchased under the plans or programs Jan 1- Jan 31, 2022 21,955 $5.03 — — Feb 1- Feb 28, 2022 1,787 $4.42 — — Mar 1- Mar 31, 2022 389,878 $4.84 389,878 1,594,136 Total 413,620 $4.85 389,878 1,594,136 (1) This amount includes 23,742 common shares acquired at a cost of $119,000 to satisfy employee income tax withholding associated with RSUs vestings. (2) On March 7, 2022, the Company's Board of Directors authorized and approved a share repurchase program on Nasdaq. Under the terms of the 2022 Share Repurchase Program, the Company may repurchase up to 1,984,014 of its common shares from time to time through open market purchases, block purchases or otherwise in accordance with applicable securities laws, including Rule Page 36 VIEMED HEALTHCARE, INC. March 31, 2022 and 2021 10b-18 of the Exchange Act. The Share Repurchase Program does not have an expiration date and may be suspended or discontinued at any time. Dividends We have not declared or paid any cash or stock dividends on our common shares since our inception and do not anticipate declaring or paying any cash or stock dividends in the foreseeable future. Our subsidiaries are restricted from making distributions or dividend payments to us by the Loan Agreement, subject to certain exceptions. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures Not applicable.